Clinical Trials Logo

Clinical Trial Summary

This study will be conducted in accordance with the local regulation of New Drug Application. Overall duration of this trial will be 3 years after approval of KFDA.

Each subject will participate around 7 weeks, which include the 2 weeks Amlodipine run-in period, 4 weeks double blind period and 1 week safety follow up period


Clinical Trial Description

A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel group, Therapeutic confirmatory Study.

The subject who has at least one episode of chest pain weekly and at least two episodes of chest pain during last week despite Amlodipine 5mg qd taking during 2 weeks will have treatment of Pletaal(Cilostazol) or Placebo for 4 weeks. Pletaal(Cilostazol) is taken 100mg oral tablets bid during 2 weeks after dosing of Pletaal(Cilostazol) 50mg oral tablets bid during 2 weeks. Placebo of Pletaal(Cilostazol) is used as the control medication. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02087007
Study type Interventional
Source Korea Otsuka Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 3
Start date November 2013
Completion date July 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04827498 - Myocardial Ischemia Without Obstructive Coronary Stenoses
Recruiting NCT05294887 - Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Phase 4
Recruiting NCT06401291 - Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries N/A
Recruiting NCT05313919 - Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis
Not yet recruiting NCT06424834 - Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries Phase 2/Phase 3
Not yet recruiting NCT06415227 - The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris Phase 2
Recruiting NCT05282511 - A Multi-Omics Study of Vasospastic Angina
Recruiting NCT04674449 - iCorMicA - Stratified Medicine in Angina N/A
Completed NCT02094469 - Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina Phase 3
Recruiting NCT02180971 - Multidetector Coronary CT In Vasospastic Angina N/A
Completed NCT00602017 - Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions N/A
Completed NCT00601302 - Bioequivalency Study of Amlodipine Tablets Under Fed Conditions N/A